Tenon Medical (TNON) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
23 Jul, 2026Opening remarks and agenda
CEO welcomed attendees, introduced board members and executive officers, and outlined the meeting structure.
Independent auditor and Inspector of Election were introduced, with roles explained.
Voting procedures and meeting logistics were detailed, including how to vote and ask questions.
Board and executive committee updates
Board composition highlighted, including new and existing directors and their committee roles.
Executive officers and independent auditor were present to address questions.
Shareholder proposals
Six proposals were presented: election of directors, auditor appointment, reverse stock split, debt financing, future financings, and potential adjournment.
Board unanimously recommended approval of all proposals.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Tenon Medical
- Q2 2026 revenue up 127% with 64% gross margin, but losses and liquidity risks remain.TNON
Q2 2026 - Registering up to $100M in securities, targeting SI joint market, but faces financial and listing risks.TNONRegistration filing
- Clarifies voting thresholds for major proposals and outlines auditor ratification process.TNONProxy filing
- Raising up to $3.5M via shares and warrants to fund growth, repay debt, and address Nasdaq compliance.TNONRegistration filing
- Board seeks approval for director elections, reverse stock split, and key financing proposals.TNONProxy filing
- IPO offers shares and warrants to fund expansion, repay debt, and support R&D amid Nasdaq risks.TNONRegistration filing
- Registering 6.3M shares for resale, company targets SI joint market but faces dilution and going concern risks.TNONRegistration filing
- Shareholders will vote on director elections, a reverse stock split, and key financing approvals.TNONProxy filing
- Q2 revenue up 21%, gross margin at 52%, but going concern risk remains.TNONQ2 2024